Update on epinephrine for the treatment of anaphylaxis

Current Opinion in Pediatrics

Volumn 19, Issue 1, 2007, Pages 94-98

  Pongracic, Jacqueline A ^a,b   Kim, Jennifer S ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Anaphylaxis; Autoinjectors; Epinephrine

Indexed keywords

ADRENALIN; SALBUTAMOL;

ACUTE DISEASE; ANAPHYLAXIS; ASTHMA; DAY CARE; DEVICE; DISEASE CLASSIFICATION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG METABOLISM; DRUG SELF ADMINISTRATION; HUMAN; LONG TERM CARE; MEDICAL EDUCATION; PEANUT; PEDIATRICIAN; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; REVIEW; SELF INJECTION; SOCIAL STATUS; TREATMENT PLANNING;

ADMINISTRATION, SUBLINGUAL; ADRENERGIC AGONISTS; ANAPHYLAXIS; ANIMALS; EPINEPHRINE; HUMANS; INJECTIONS, INTRAMUSCULAR; PARENTS; PHYSICIANS, FAMILY; SCHOOLS;

EID: 33846287241     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328012316b     Document Type: Review

References (32)

1. Sampson HA, Munoz-Furlong A, Bock SA, et al. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 2005; 115:584-591.
2. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117:391-397. Authored by an expert panel, this outlines the criteria for diagnosis and reviews management of acute anaphylaxis.
3. Lieberman P, Kemp SF, Oppenheimer J, et al. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 2005; 115:S483-S523. This comprehensive review provides the practicing physician with an evidence-based approach to diagnosis and management of anaphylaxis.
4. Yocum MW, Butterfield JH, Klein JS, et al. Epidemiology of anaphylaxis in Olmsted County: a population-based study. J Allergy Clin Immunol 1999; 104(2 Pt 1):452-456.
5. Gupta R, Sheikh A, Strachan DP, et al. Time trends in allergic disorders in the UK. Thorax September 2006; 1-6. This study demonstrates that healthcare usage for allergic disorders, particularly anaphylaxis and food allergy, has been increasing rapidly in recent years.
6. Grouhi M, Alshehri M, Hummel D, Roifman CM. Anaphylaxis and epinephrine auto-injector training: who will teach the teachers? J Allergy Clin Immunol 1999; 104:190-193.
7. Sicherer SH, Forman JA, Noone SA. Use assessment of self-administered epinephrine among food-allergic children and pediatricians. Pediatrics 2000; 105:359-362.
8. Wang J, Sicherer SH, Nowak-Wegrzyn A. Primary care physicians' approach to food-induced anaphylaxis: a survey. J Allergy Clin Immunol 2004; 114:689-691.
9. Clark S, Long AA, Gaeta TJ, Camargo CA Jr. Multicenter study of emergency department visits for insect sting allergies. J Allergy Clin Immunol 2005; 116:643-649.
10. Sampson HA. Update on food allergy. J Allergy Clin Immunol 1999; 104:452-456.
11. Krugman SD, Chiaramonte DR, Matsui EC. Diagnosis and management of food-induced anaphylaxis: a national survey of pediatricians. Pediatrics 2006; 118:e554-e560. This study highlights knowledge deficits among pediatricians that may impair optimal care to children with food-induced anaphylaxis.
12. Mehl A, Wahn U, Niggemann B. Anaphylactic reactions in children: a questionnaire-based survey in Germany. Allergy 2005; 60:1440-1445.
13. Ferreira MB, Alves RR. Are general practitioners alert to anaphylaxis diagnosis and treatment? Allerg Immunol 2006; 38:83-86.
14. Sicherer SH, Simons FE. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. J Allergy Clin Immunol 2005; 15:575-583. Examples of clinical scenarios and potential pitfalls in anaphylaxis management are reviewed. This perspective provides a practical yet thoughtful approach for clinicians.
15. Simons FE. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol 2006; 117:367-377. This reviews management issues beyond the acute treatment of anaphylaxis and identifies the clinician's role in risk reduction and education.
16. Uguz A, Lack G, Pumphrey R, et al. Allergic reactions in the community: a questionnaire survey of members of the anaphylaxis campaign. Clin Exp Allergy 2005; 35:746-750.
17. Pouessel G, Deschildre A, Castelain C, et al. Parental knowledge and use of epinephrine auto-injector for children with food allergy. Pediatr Allergy Immunol 2006; 17:221-226.
18. Kim JS, Sinacore JM, Pongracic JA. Parental use of EpiPen for children with food allergies. J Allergy Clin Immunol 2005; 116:164-168. This is the first study to identify psychological factors that may contribute to underutilization of epinephrine as treatment for anaphylaxis.
19. Barnett CW. Need for community pharmacist-provided food-allergy education and auto-injectable epinephrine training. J Am Pharm Assoc 2005; 45:479-485.
20. Simons FER, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 2001; 108:871-873.
21. Song TT, Nelson MR, Chang JH, et al. Adequacy of the epinephrine autoinjector needle length in delivering epinephrine to the intramuscular tissues. Ann Allergy Asthma Immunol 2005; 94:539-544. This study compares thigh skin-to-muscle distance with EpiPen needle length and finds that the EpiPen is unlikely to deliver epinephrine intramuscularly in many women.
22. Rawas-Qalaji MM, Simons FE, Simons KJ. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis. J Allergy Clin Immunol 2006; 117:398-403. This animal study demonstrates dose equivalence for a rapidly dissolving sublingual epinephrine tablet as compared with intramuscular injection. As self-injectable epinephrine is underused, sublingual epinephrine may be a feasible alternative.
23. Rawas-Qalaji MM, Simons FE, Simons KJ. Epinephrine for the treatment of anaphylaxis: do all 40 mg sublingual epinephrine tablet formulations with similar in vitro characteristics have the same bioavailability? Biopharm Drug Dispos 2006; 27:427-435.
24. McIntyre CL, Sheetz AH, Carroll CR, Young MC. Administration of epinephrine for life-threatening allergic reactions in school settings. Pediatrics 2005; 116:1134-1140. This study elucidates information about anaphylaxis events and practices in schools. The findings are important and provide guidance for developing school-based emergency policies.
25. Hannaway PJ, Connelly ME, Cobbett RM, Dobrow PJ. Differences in race, ethnicity, and socioeconomic status in schoolchildren dispensed injectable epinephrine in 3 Massachusetts school districts. Ann Allergy Asthma Immunol 2005; 95:143-148. This study uncovered significant racial, ethnic and socioeconomic differences in recognition of allergic disorders and availability of epinephrine among school-children.
26. Frost DW, Chalin CG. The effect of income on anaphylaxis preparation and management plans in Toronto primary schools. Can J Public Health 2005; 96:250-253.
27. Olympia RP, Wan E, Avner JR. The preparedness of schools to respond to emergencies in children: a national survey of school nurses. Pediatrics 2005; 116:e738-e745.
28. Rankin KE, Sheikh A. Serious shortcomings in the management of children with anaphylaxis in Scottish schools. PLOS Medicine 2006; 3:e326.
29. Bansal PJ, Marsh R, Patel B, Tobin MC. Recognition, evaluation, and treatment of anaphylaxis in the child care setting. Ann Allergy Asthma Immunol 2005; 94:55-59. This is the first study to examine anaphylaxis practices in child-care centers. It is also the first to evaluate an intervention to improve recognition and treatment of anaphylaxis in such centers.
30. Murphy KR, Hopp RJ, Kittelson EB, et al. Life-threatening asthma and anaphylaxis in schools: a treatment model for school-based programs. Ann Allergy Asthma Immunol 2006; 96:398-405.
31. Simons FE. Lack of worldwide availability of epinephrine autoinjectors for outpatients at risk of anaphylaxis. Ann Allergy Asthma Immunol 2005; 94:534-538. This study highlights concerns about international availability and affordability of epinephrine autoinjectors.
32. Fitzharris P, Empson M, Ameratunga R, et al. Anaphylaxis management: the essential role of adrenaline (epinephrine) auto-injectors - should PHARMAC fund them in New Zealand? N Z Med J 2006; 119:U1965.